Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8

被引:62
作者
Pericolini, E
Cenci, E
Monari, C
De Jesus, M
Bistoni, F
Casadevall, A
Vecchiarelli, A [1 ]
机构
[1] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
D O I
10.1111/j.1462-5822.2005.00619.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The major virulence factor of Cryptococcus neoformans is its polysaccharide capsule composed of glucuronoxylomannan (GXM), galactoxylomannan (GalXM) and mannoproteins. A variety of immunomodulating activities have been described for GXM and mannoproteins but little is known about possible interactions of GalXM with the immune system. In the present article, we investigate the effect of purified soluble GalXM on human T lymphocytes. The results indicate that, GalXM (i) can affect selected immune responses; (ii) causes significant impairment of T cell proliferation and increases interferon-gamma and interleukin-10 production; and (iii) induces apoptosis of T lymphocytes through activation of caspase-8 that terminates with fragmentation of DNA. These results are the first to suggest a role for GalXM in C. neoformans virulence by demonstrating that it can target human T cells, and that it may impair the development of an effective specific T cell response.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 35 条
[1]   The CD95 type I/type II model [J].
Barnhart, BC ;
Alappat, EC ;
Peter, ME .
SEMINARS IN IMMUNOLOGY, 2003, 15 (03) :185-193
[2]   Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10 [J].
Barreiro, R ;
Luker, G ;
Herndon, J ;
Ferguson, TA .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :1519-1525
[3]   Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mono-nuclear cells [J].
Chaka, W ;
Verheul, AFM ;
Vaishnav, VV ;
Cherniak, R ;
Scharringa, J ;
Verhoef, J ;
Snippe, H ;
Hoepelman, IM .
INFECTION AND IMMUNITY, 1997, 65 (01) :272-278
[4]   STRUCTURE AND ANTIGENIC ACTIVITY OF THE CAPSULAR POLYSACCHARIDE OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
SLODKI, ME ;
PLATTNER, RD ;
BLUMER, SO .
MOLECULAR IMMUNOLOGY, 1980, 17 (08) :1025-1032
[5]   Apoptosis and transplantation tolerance [J].
Chiffoleau, E ;
Walsh, PT ;
Turka, L .
IMMUNOLOGICAL REVIEWS, 2003, 193 (01) :124-145
[6]   God must love galectins; He made so many of them [J].
Cooper, DNW ;
Barondes, SH .
GLYCOBIOLOGY, 1999, 9 (10) :979-984
[7]   Tumor necrosis factor-inducing activities of Cryptococcus neoformans components [J].
Delfino, D ;
Cianci, L ;
Migliardo, M ;
Mancuso, G ;
Cusumano, V ;
Corradini, C ;
Teti, G .
INFECTION AND IMMUNITY, 1996, 64 (12) :5199-5204
[8]   Cryptococcal polysaccharides bind to CD18 on human neutrophils [J].
Dong, ZM ;
Murphy, JW .
INFECTION AND IMMUNITY, 1997, 65 (02) :557-563
[9]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[10]   Differential requirement for Caspase 9 in apoptotic pathways in vivo [J].
Hakem, R ;
Hakem, A ;
Duncan, GS ;
Henderson, JT ;
Woo, M ;
Soengas, MS ;
Elia, A ;
de la Pompa, JL ;
Kagi, D ;
Khoo, W ;
Potter, J ;
Yoshida, R ;
Kaufman, SA ;
Lowe, SW ;
Penninger, JM ;
Mak, TW .
CELL, 1998, 94 (03) :339-352